Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Join us for a discussion on the critical intersection of diabetes and liver disease. Our guest, Sarah Bauer, a pediatrician, shares her personal journey and insights into …
Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data. Wegovy, a drug that is approved for weight loss, is covered by just 1% of Marketplace…
In this special sponsored episode from Sanofi, we welcome Jennifer Goldman. She is a professor of pharmacy at the Massachusetts College of Pharmacy and Health Sciences, board-certified in advanced diabetes management, and a certified diabetes care and …
The Canadian federal government’s decision to cover diabetes medication and devices under its new pharmacare plan is a significant step forward in improving the quality of life for the millions of Canadians with diabetes, especially those who str…
The makers of Ozempic and Mounjaro charge list prices of around $1,000 a month for the diabetes and obesity drugs, and insurers are reluctant to pick up the tab. Often, low-income patients have to resort to less effective treatments.
Why bother going to work? If I didn’t work, I wouldn’t get paid, so there was that. But it seemed like a pointless exercise. I would stare at my monitor until it was time to go home. On some level I knew I should be, well, working, but I co…
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! We delve into the challenges faced by individuals who navigate complex health care systems with multiple chronic conditions. Our guest, Gary Marc Rothenberg, a podiatrist,…
KFF’s latest Health Tracking Poll examines the public’s views and use of an an increasingly popular class of prescription drugs used for weight loss and to treat diabetes or prevent heart attacks or strokes. The poll finds 12% of adults report having t…
About one in eight adults (12%) say they have taken one of an increasingly popular class of prescription drugs known as GLP-1s that are used for weight loss and to treat diabetes and reduce the risk of heart disease and stroke, a new KFF Health Trackin…
An excerpt from Sugar Free. “What do you want to do?” Ginny said. “Chinese jump rope.” “Tilly, you always want to play Chinese jump rope,” Renée said. “So?” Tilly said. Renée didn’t have an answer t…
